Evidence map›Paper›PMID 41333771›Full record

ArticleFrontiers in medicine2025

Prevalence of vision impairment in Rwanda: a hospital-based study.

Benedict Ayobi, Rekha Hansraj, Nishanee Rampersad, Gerard Urimubenshi

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benedict AyobiDiscipline of Optometry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Rekha HansrajDiscipline of Optometry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Nishanee RampersadDiscipline of Optometry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Gerard UrimubenshiDepartment of Physiotherapy, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Vision impairment (VI) is a global health challenge with its impact cutting across ages, gender, and all domains of life. A shift in global demographics due to increasing life expectancy is expected to increase the burden of VI. Aim: This study sought to determine the prevalence of VI in the general population among selected public hospitals in Kigali and southern Rwanda. Methods: This retrospective hospital-based study used five public hospitals from Kigali and Southern Rwanda. Patient files from 1st January 2018 to 31st December 2023 were sampled, and files with VI according to defined criteria were selected, and data were collected. Data were analyzed using descriptive and inferential statistics. Results: Most patients who presented to the hospitals were female (60.7%). The prevalence of VI ranged between 8.1 and 18.2%. VI was more prevalent in females than in males (18.0% vs. 13.7%). Additionally, VI was most prevalent among the elderly (29.1%). The leading causes of VI were diseases of the lens and normal globe diseases. The risk of VI was significantly higher in males (AOR: 1.25; 95% CI: 1.16-1.34), the elderly (AOR: 1.57; 95% CI: 1.40-1.76), and those with diseases of the lens (AOR: 2.17; 95% CI: 1.88-2.51). Conclusion: The burden of VI in Rwanda is expected to increase due to a growing youthful population. Sustained efforts, including improving human resources and addressing the unmet demands of cataract and refractive error, are critical to avert the impending public health challenge.

Indexed as

blindnesscataractsrefractive errorRwandavision impairment

Identifiers

PMID41333771
PMCPMC12665563

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.